Seres Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Seres Therapeutics (MCRB) Reports In-Line Q1 EPS, Revenues Miss
May 7, 2020 7:57 AM EDTSeres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.28), in-line with the analyst estimate of ($0.28). Revenue for the quarter came in at $8.19 million versus the consensus estimate of $8.53 million.
We were pleased to have recently achieved the important milestone of completing enrollment of our... More
